{
  "metadata": {
    "label": "COPD - Null Scenario",
    "description": "Scenario with all interventions scaled to 0% coverage, representing no intervention implementation.\nThis null scenario sets target coverage to zero for all COPD-specific interventions: Inhaled Salbutamol, Ipratropium Inhaler, and Oral Prednisolone.\nAlso sets coverage to zero for all tobacco control interventions including protection policies, cessation programs, warning labels, mass media campaigns, and advertising bans.\nThis scenario serves as a counterfactual baseline to measure the full impact of intervention packages by comparing against a state with no interventions.\nUseful for calculating total health gains, deaths averted, and disability-adjusted life years (DALYs) prevented when interventions are implemented from zero coverage.\n",
    "authors": [],
    "date_created": "2025-08-12 17:07"
  },
  "parameters": {
    "Country": {
      "hidden": true,
      "value": "AFG",
      "paths": [
        "$.nodes[?(@.id=='lrso81aw')].generate_array.parameters.country",
        "$.nodes[?(@.id=='lrso71jf')].generate_array.parameters.country",
        "$.nodes[?(@.id=='lrso7mga')].generate_array.parameters.country",
        "$.nodes[?(@.id=='DsFreeSus')].generate_array.parameters.country",
        "$.nodes[?(@.id=='Mn5YBbsp')].generate_array.parameters.country",
        "$.nodes[?(@.id=='HvEhBiqV')].generate_array.parameters.country",
        "$.nodes[?(@.id=='wdoGuxrz')].generate_array.parameters.country",
        "$.links[?(@.id=='3gSm1z84')].generate_array.parameters.country",
        "$.links[?(@.id=='6dXmRQ7e')].generate_array.parameters.country",
        "$.links[?(@.id=='JPGqVn1u')].generate_array.parameters.country",
        "$.links[?(@.id=='k3JrWa6h')].generate_array.parameters.country",
        "$.links[?(@.id=='MfWskKJT')].generate_array.parameters.country",
        "$.links[?(@.id=='eBRm4kvr')].generate_array.parameters.country",
        "$.links[?(@.id=='WALgwDoi')].generate_array.parameters.country",
        "$.links[?(@.id=='HmI3Gkua')].generate_array.parameters.country",
        "$.links[?(@.id=='cz2LeDKw')].generate_array.parameters.country"
      ]
    },
    "Inhaled Salbutamol Baseline Coverage": {
      "category": "Coverage",
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso22do')].generate_array.parameters.value",
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.start_value",
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.fill_before"
      ]
    },
    "Inhaled Salbutamol Target Coverage": {
      "category": "Coverage",
      "value": 0,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.end_value",
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.fill_after"
      ]
    },
    "Inhaled Salbutamol Scale-Up Start Year": {
      "value": 0,
      "description": "The index when scale-up starts for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.start_index"
      ],
      "category": "Coverage"
    },
    "Inhaled Salbutamol Scale-Up Final Year": {
      "value": 1,
      "description": "The index when scale-up ends for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.end_index"
      ],
      "category": "Coverage"
    },
    "Inhaled Salbutamol Population In Need": {
      "category": "Population in Need",
      "value": 1,
      "description": "The proportion of persons who require the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnavq2')].generate_array.parameters.value"
      ]
    },
    "Inhaled Salbutamol Disability Impact": {
      "category": "Intervention Effects",
      "value": 0.148,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjkmt')].generate_array.parameters.value"
      ]
    },
    "Ipratropium Inhaler Baseline Coverage": {
      "category": "Coverage",
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnhyyd')].generate_array.parameters.value",
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.start_value",
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.fill_before"
      ]
    },
    "Ipratropium Inhaler Target Coverage": {
      "category": "Coverage",
      "value": 0,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.end_value",
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.fill_after"
      ]
    },
    "Ipratropium Inhaler Scale-Up Start Year": {
      "value": 0,
      "description": "The index when scale-up starts for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.start_index"
      ],
      "category": "Coverage"
    },
    "Ipratropium Inhaler Scale-Up Final Year": {
      "value": 1,
      "description": "The index when scale-up ends for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.end_index"
      ],
      "category": "Coverage"
    },
    "Ipratropium Inhaler Disability Impact": {
      "category": "Intervention Effects",
      "value": 0.169,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjr1s')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Baseline Coverage": {
      "category": "Coverage",
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso28l8')].generate_array.parameters.value",
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.start_value",
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.fill_before"
      ]
    },
    "Oral Prednisolone Target Coverage": {
      "category": "Coverage",
      "value": 0,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.end_value",
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.fill_after"
      ]
    },
    "Oral Prednisolone Scale-Up Start Year": {
      "value": 0,
      "description": "The index when scale-up starts for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.start_index"
      ],
      "category": "Coverage"
    },
    "Oral Prednisolone Scale-Up Final Year": {
      "value": 1,
      "description": "The index when scale-up ends for this intervention, where 0 == the first year of the time horizon",
      "paths": [
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.end_index"
      ],
      "category": "Coverage"
    },
    "Oral Prednisolone Population In Need": {
      "category": "Population in Need",
      "value": 0.12,
      "description": "The proportion of persons who require the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsngte4')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Disability Impact": {
      "category": "Intervention Effects",
      "value": 0.337,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjnt3')].generate_array.parameters.value"
      ]
    }
  }
}